Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|July 25, 2018
[Gastrografin as a prognostic and therapeutic medium; use for small bowel obstruction, but not for closed loop obstruction]Ariane A van Loevezijn, Robin H M Smithuis, Jephta van den Bremer
Nederlands Tijdschrift Voor Geneeskunde|January 21, 2016
[Breast-specific gamma imaging in breast cancer]Ariane A van Loevezijn, Adriaan C van Breda Vriesman, Peter A Neijenhuis, et al.
Breast Cancer Research and Treatment|January 2, 2023
Clinical impact of MRI-detected additional lesions in breast cancer patients with neoadjuvant systemic therapy at the Netherlands cancer instituteAriane A van Loevezijn, Hillegonda A O Winter-Warnars, Genevieve S Hernández, et al.
Annals of Surgical Oncology|April 18, 2023
Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA TrialAnnemiek K E van Hemert, Frederieke H van Duijnhoven, Ariane A van Loevezijn, et al.
Breast Cancer Research and Treatment|January 23, 2023
Immediate or delayed oncoplastic surgery after breast conserving surgery at the Netherlands Cancer Institute: a cohort study of 251 casesAriane A van Loevezijn, Charissa S Geluk, Marieke J van den Berg, et al.
Breast Cancer Research and Treatment|January 8, 2024
Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcomeAnnemiek van Hemert, Ariane A van Loevezijn, Anne Bosman, et al.
EJNMMI Research|August 21, 2021
[18F]FDG-PET/CT in prone compared to supine position for optimal axillary staging and treatment in clinically node-positive breast cancer patients with neoadjuvant systemic therapyAriane A van Loevezijn, Marcel P M Stokkel, Maarten L Donswijk, et al.
Nuclear Medicine Communications|March 10, 2023
Clinical impact of molecular breast imaging as adjunct diagnostic modality in evaluation of indeterminate breast abnormalities and unresolved diagnostic concernsAriane A van Loevezijn, Christinne L S Corion, Anneke M Zeillemaker, et al.
JAMA Oncology|August 28, 2025
Iodine Seed-Marking Protocol for Response-Guided Axillary Treatment After Systemic Therapy for Node-Positive Breast CancerAnnemiek K E van Hemert, Ariane A van Loevezijn, Marie-Sophie P D Baas, et al.
Breast (Edinburgh, Scotland)|February 15, 2025
Omitting axillary lymph node dissection in breast cancer patients with extensive nodal disease and excellent response to primary systemic therapy using the MARI protocolAnnemiek K E van Hemert, Ariane A van Loevezijn, Marie-Sophie P D Baas, et al.
Pageof 2